RxDoctor Payments Data

Leyda Su Ham, DO

Family Medicine · Cudahy, WINPI 1912169657

Payments from drug & device makers

$2,720in general payments, 2019–2025

Across 161 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1K
  • Viiv Healthcare Company$873
  • Merck$331
  • Theratechnologies Inc.$159
  • Johnson & Johnson$71
  • GSK$53
  • plus $131 from 6 others

What the payments were for

  • Food & beverage$2,720100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,720 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$38,356
Medicare patients
86
Services billed
470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala117$455,418
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf13$64,527
GenvoyaElviteg/Cob/Emtri/Tenof Alafen13$49,873
TrulicityDulaglutide48$48,984
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$45,367
JulucaDolutegravir/Rilpivirine12$38,696
XareltoRivaroxaban22$35,973
LinzessLinaclotide47$33,016
EliquisApixaban37$25,390
MyrbetriqMirabegron31$22,489
IsentressRaltegravir Potassium11$22,083
OzempicSemaglutide14$20,515
RybelsusSemaglutide18$17,796
Combivent RespimatIpratropium/Albuterol Sulfate34$16,687
JardianceEmpagliflozin18$16,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya$1,102$505,292130 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$53$58,84093 claims
Viiv Healthcare CompanyJuluca$873$38,69612 claims
Novo NordiskOzempic, Rybelsus$16$38,31132 claims
Johnson & JohnsonXarelto$71$35,97322 claims
AbbVieLinzess$33$33,01647 claims
MerckIsentress, Januvia$331$31,18426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Cudahy

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →